Invokana Lawsuit: Plaintiff Claims Side Effects Of Diabetes Drug Caused Onset of Diabetic Ketoacidosis

April 27, 2016 – – TheProductLawyers.com reports on an Invokana lawsuit centered on a particular alleged side effect – diabetic ketoacidosis. The lawsuit, filed in the Southern District of Alabama under case number 1:15-cv-00636, alleges that the plaintiff began taking Invokana, a new-generation, type-2 diabetes drug, in December 2014 and shortly after that developed a case of ketoacidosis, a potentially life threatening condition.

Additional details in the court papers show that the plaintiff believed that Janssen Pharmaceuticals, the manufacturer of Invokana, abdicated its responsibility to inform the general public about this dangerous side effect and that the manufacturer did not sufficiently study the drug’s effectiveness with an adequate amount of time to get more definitive results.

The plaintiff also claims that she was not made aware of the diabetic ketoacidosis risk for patients taking Invokana and alleges that manufacturer Janssen Pharmaceuticals marketed the drug “off-label.” She claims negligence due to failing to adequately issue warnings about dangerous potential side effects associated with the drug.

When a drug is considered “Off-label” it means it was not approved by the FDA but still marketed by the manufacturer. Invokana was approved to treat type-2 diabetes but not type 1, but as per the plaintiff, Janssen did indeed market it as a treatment for Type 1 as well.

Diabetic ketoacidosis is a condition that can occur in as little as 24 hours and is when the bloodstream has an inordinately high level of toxic acid or ketones in it . A patient can become comatose or even die if the condition is not treated immediately.

The U.S. Food and Drug Administration (FDA) has issued a public safety announcement about the potential side effect and possible linkage to taking Invokana or one of the other SGLT2 inhibitor drugs. The agency is asking that patients be acutely aware of the symptoms of ketoacidosis, which, according to the Mayo Clinic, can encompass confusion, shortness of breath, excessive thirst or day mouth, having to urinate a lot, and abdominal pain.

For more information about the Invokana lawsuits, or this press release, please contact TheProductLawyers.com on 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009583